Archive for the ‘EU policy’ Category
About this blog
The Internet holds the power to profoundly change the way healthcare is delivered. Millions of patients, caregivers and physicians turn to the Internet every day to look up the latest information on important health topics and find support from like-minded people.
Categories
- #hcsmeu (11)
- Access (8)
- Adherence (3)
- Adverse Events (1)
- Awareness (6)
- EU policy (3)
- Events (3)
- government (5)
- Guidance (5)
- Non classé (2)
- Online community (11)
- Patient-focus (16)
- Regulations (6)
- Social media tools (23)
- strategy (15)
- twitter (13)
- Matt Owen: Despite increasing adoption, there's still a tendency by many businesses (not just Pharma) to funnel [...]
- Dana Webster: I've only been able to loosely follow the conversation and to glance at the entire Roche document. [...]
- Andrew Spong: Hi Silja It was a great idea of yours to collate these opinions into a video, and thank you for a [...]
- Does it matter that Roche published its social media guidance? - whydot pharma: [...] Non classé 23 août 2010 As promised here, please find now below the first video on the R [...]
- The white elephant in the room: the FDA hearing and DTC | Treat My Brand | Haider Alleg: [...] DTC TV ads and despise the idea of it leaking into their social media haven. And I have to agr [...]
- Roche guidance won’t impact us…but it might impact our convo
- Does Roche need to separate social media guidance into personal and professional?
- Is the Roche social media guidance clear?
- Does it matter that Roche published its social media guidance?
- Opinion poll on Roche social media guidance
- E-patients’ moments-of-truth are social
- Pharma social media? Or pharma engagement in social media?
- Fake Sara ticks me off. Get real Medseek!
- How to run an unconference: an introduction to #hcsmeucamp
- Pharma twittersphere- who is following you- Part III